2004年的私营生物技术公司——数据
Private biotech 2004--the numbers.
作者信息
Hodgson John
机构信息
Critical I Limited, The Colin Sanders Innovation Centre, Mewburn Road, Banbury, OX16 9PA, UK.
出版信息
Nat Biotechnol. 2006 Jun;24(6):635-41. doi: 10.1038/nbt0606-635.
PMID:16763589
Abstract
Compared with the plethora of financial information about the publicly traded elite of the biotech world, little is known about the multitude of private biotech firms. Here, Nature Biotechnology's Editor-at-Large provides an analysis of the financial performance of the privately held biotech sector.
摘要
与生物科技领域上市巨头们大量的财务信息相比，人们对众多私营生物科技公司却知之甚少。在此，《自然·生物技术》的特约编辑对私营生物科技行业的财务表现进行了分析。
相似文献
1
Private biotech 2004--the numbers.
Nat Biotechnol. 2006 Jun;24(6):635-41. doi: 10.1038/nbt0606-635.
2
State of biotech sector--2005.
Nat Biotechnol. 2006 Jun;24(6):603. doi: 10.1038/nbt0606-603.
3
Public biotechnology 2005--the numbers.
Nat Biotechnol. 2006 Jun;24(6):625-34. doi: 10.1038/nbt0606-625.
4
Public biotechnology 2003-the numbers.
Nat Biotechnol. 2004 Jun;22(6):665-70. doi: 10.1038/nbt0604-665.
5
Public biotech 2006 - the numbers.
Nat Biotechnol. 2007 Jul;25(7):729-37. doi: 10.1038/nbt0707-729.
6
Public biotechnology 2002--the numbers.
Nat Biotechnol. 2003 Jun;21(6):607-12. doi: 10.1038/nbt0603-607.
7
Public biotech 2007--the numbers.
Nat Biotechnol. 2008 Jul;26(7):753-62. doi: 10.1038/nbt0708-753.
8
Growth and profitability in small privately held biotech firms: preliminary findings.
N Biotechnol. 2009 Jun;25(5):369-76. doi: 10.1016/j.nbt.2009.03.006. Epub 2009 Apr 5.
9
2007--a banner year for biotech.
Nat Biotechnol. 2008 Feb;26(2):150. doi: 10.1038/nbt0208-150.
10
Lack of private financing hobbles emerging biotech regions.
Nat Biotechnol. 2006 Jan;24(1):7-9. doi: 10.1038/nbt0106-7.
引用本文的文献
1
Laying the foundations for a bio-economy.
Syst Synth Biol. 2007 Aug;1(3):109-17. doi: 10.1007/s11693-007-9010-z. Epub 2008 Feb 6.
Zotero 插件